North America High-Flow Nasal Cannula Market Report – Research, Industry Analysis Reports and Market Demands

North America High-Flow Nasal Cannula Market to 2027- Regional Analysis and Forecasts by Component (Air Oxygen Blender, Nasal Cannula, Heated Inspiratory Circuit, and Active Humidifier); Application (Bronchiectasis, Acute Respiratory Failure, Acute Heart Failure, and Chronic Obstructive Pulmonary Disease); End User (Ambulatory Care Centers, Hospitals and Long-Term Care Centers) and Country

Request for Sample of this report

Buy now

Table of Content

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance

2. North America High-Flow Nasal Cannula Market – Key Takeaways

3. North America High-Flow Nasal Cannula Market – Market Landscape

3.1 Overview
3.2 Market Segmentation
- 3.2.1 North America High-Flow Nasal Cannula Market – By Component
- 3.2.2 North America High-Flow Nasal Cannula Market – By Application
- 3.2.3 North America High-Flow Nasal Cannula Market – By End User
- 3.2.4 North America High-Flow Nasal Cannula Market – By North America Countries
3.3 PEST Analysis

4. North America High-Flow Nasal Cannula Market - Key Market Dynamics

4.1 Key Market Drivers
- 4.1.1 Increasing Lung Cancer Conferences Across North America
- 4.1.2 Growing Asthma Cases in Adults and Children
4.2 Key Market Restraints
- 4.2.1 Side Effects Associated with High Flow Nasal Cannula
4.3 Key Market Opportunity
- 4.3.1 Growing Geriatric Population
4.4 Future Trend
- 4.4.1 Increasing Acceptance of Home Oxygen Therapy
4.5 Impact Analysis

5. High-Flow Nasal Cannula Market – North America Analysis

5.1 North America High-Flow Nasal Cannula Market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 Performance of Key Players
- 5.3.1 Fisher & Paykel Healthcare Limited
- 5.3.2 ResMed

6. North America High-Flow Nasal Cannula Market Analysis – By Component

6.1 Overview
6.2 Component market Revenue and Forecasts Analysis (US$ Mn)
6.3 Air Oxygen Blender
- 6.3.1 Overview
- 6.3.2 North America Air Oxygen Blender Market Revenue and Forecast to 2027 (US$ Mn)
6.4 Nasal Cannula
- 6.4.1 Overview
- 6.4.2 North America Nasal Cannula Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Heated Inspiratory Circuit
- 6.5.1 Overview
- 6.5.2 North America Heated Inspiratory Circuit Market Revenue and Forecast to 2027 (US$ Mn)
6.6 Active Humidifier
- 6.6.1 Overview
- 6.6.2 North America Active Humidifier Market Revenue and Forecast to 2027 (US$ Mn)

7. North America High-Flow Nasal Cannula Market Analysis – By Application

7.1 Overview
7.2 North America High-Flow Nasal Cannula Market, by Application 2018 & 2027 (%)
7.3 Bronchiectasis
- 7.3.1 Overview
- 7.3.2 North America Bronchiectasis Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Acute Respiratory Failure
- 7.4.1 Overview
- 7.4.2 North America Acute Respiratory Failure Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Acute Heart Failure
- 7.5.1 Overview
- 7.5.2 North America Acute Heart Failure Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Chronic Obstructive Pulmonary Disease
- 7.6.1 Overview
- 7.6.2 North America Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2027 (US$ Mn)

8. North America High-Flow Nasal Cannula Market Analysis – By End User

8.1 Overview
8.2 North America High-Flow Nasal Cannula Market, by Applicaton 2018 & 2027 (%)
8.3 Ambulatory Surgical Centers
- 8.3.1 Overview
- 8.3.2 North America Ambulatory Surgical Centers Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Hospitals
- 8.4.1 Overview
- 8.4.2 North America Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Long-Term Care Centers
- 8.5.1 Overview
- 8.5.2 North America Long-Term Care Centers Market Revenue and Forecast to 2027 (US$ Mn)

9. North America High-Flow Nasal Cannula Market Revenue And Forecasts To 2027

9.1 North America High-Flow Nasal Cannula Market
- 9.1.1 Overview
- 9.1.2 North America High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.3 North America High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
- 9.1.4 North America High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.1.5 North America High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 9.1.6 North America High-Flow Nasal Cannula Market Revenue and Forecasts to 2027, By Country (%)
- 9.1.7 Germany
  - 9.1.7.1 Germany High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
  - 9.1.7.2 Germany High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
  - 9.1.7.3 Germany High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  - 9.1.7.4 Germany High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 9.1.8 UK
  - 9.1.8.1 UK High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
  - 9.1.8.2 UK High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
  - 9.1.8.3 UK High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  - 9.1.8.4 UK High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 9.1.9 France
  - 9.1.9.1 France High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
  - 9.1.9.2 France High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
  - 9.1.9.3 France High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  - 9.1.9.4 France High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 9.1.10 Spain
  - 9.1.10.1 Spain High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
  - 9.1.10.2 Spain High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
  - 9.1.10.3 Spain High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  - 9.1.10.4 Spain High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 9.1.11 Italy
  - 9.1.11.1 Italy High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
  - 9.1.11.2 Italy High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
  - 9.1.11.3 Italy High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  - 9.1.11.4 Italy High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10. High-Flow Nasal Cannula Market –Industry Landscape
- 10.1 Overview
  - 10.1.1 Recent Developments by Players in the High-Flow Nasal Cannula Market
11. High-Flow Nasal Cannula Market–Key Company Profiles
- 11.1 Fisher & Paykel Healthcare Limited
  - 11.1.1 Key Facts
  - 11.1.2 Business Description
  - 11.1.3 Financial Overview
  - 11.1.4 Product Portfolio
  - 11.1.5 SWOT Analysis
  - 11.1.6 Key Developments
- 11.2 ResMed.
  - 11.2.1 Key Facts
  - 11.2.2 Business Description
  - 11.2.3 Financial Overview
  - 11.2.4 Product Portfolio
  - 11.2.5 SWOT Analysis
  - 11.2.6 Key Developments
- 11.3 Teleflex Incorporated
  - 11.3.1 Key Facts
  - 11.3.2 Business Description
  - 11.3.3 Financial Information
  - 11.3.4 Product Portfolio
  - 11.3.5 SWOT Analysis
  - 11.3.6 Key Developments
- 11.4 Hamilton Company
  - 11.4.1 Key Facts
  - 11.4.2 Business Description
  - 11.4.3 Financial Overview
  - 11.4.4 Product Portfolio
  - 11.4.5 SWOT Analysis
  - 11.4.6 Key Developments
- 11.5 Great Group Medical Co., Ltd.
  - 11.5.1 Key Facts
  - 11.5.2 Business Description
  - 11.5.3 Financial Information
  - 11.5.4 Product Portfolio
  - 11.5.5 SWOT Analysis
  - 11.5.6 Key Developments
- 11.6 Salter Labs (SunMed, LLC)
  - 11.6.1 Key Facts
  - 11.6.2 Business Description
  - 11.6.3 Financial Overview
  - 11.6.4 Product Portfolio
  - 11.6.5 SWOT Analysis
  - 11.6.6 Key Developments
- 11.7 TNI medical AG.
  - 11.7.1 Key Facts
  - 11.7.2 Business Description
  - 11.7.3 Financial Overview
  - 11.7.4 Product Portfolio
  - 11.7.5 SWOT Analysis
  - 11.7.6 Key Developments
- 11.8 Flexicare (Group) Limited
  - 11.8.1 Key Facts
  - 11.8.2 Business Description
  - 11.8.3 Financial Overview
  - 11.8.4 Product Portfolio
  - 11.8.5 SWOT Analysis
  - 11.8.6 Key Developments
- 11.9 Vapotherm
  - 11.9.1 Key Facts
  - 11.9.2 Business Description
  - 11.9.3 Financial Overview
  - 11.9.4 Product Portfolio
  - 11.9.5 SWOT Analysis
  - 11.9.6 Key Developments
- 11.10 MEK-ICS CO., LTD.
  - 11.10.1 Key Facts
  - 11.10.2 Business Description
  - 11.10.3 Financial Overview
  - 11.10.4 Solution Portfolio
  - 11.10.5 SWOT Analysis
  - 11.10.6 Key Developments
12. Appendix
- 12.1 About The Insight Partners
- 12.2 Glossary of Terms
- 12.3 Methodology
- 12.4 Coverage
- 12.5 Secondary Research

Description

The North America high-flow nasal cannula market is expected to reach US$ 4,261.14 Mn in 2027 from US$ 1,644.50 Mn in 2018. The market is projected to grow with a CAGR of 11.3% from 2019-2027.
The growth of the market is majorly contributed by increasing government initiatives and growing asthma cases. However, adverse effects or risk of high flow nasal cannula is likely to have a negative impact on the growth of the market in the coming years.
In the US, cases of asthma and chronic obstructive pulmonary disease (COPD) are the significant public health burdens. Governments are, therefore, taking initiatives and patient-centric national guidelines for COPD that are accessible and easy to follow by healthcare professionals. For instance, with existing COPD guidelines, the American Thoracic Society (ATS) and the global initiative for Chronic Lung Disease (GOLD), creates clinical practice guidelines that set consistent national standards for identifying people at risk for COPD as well as diagnosing and treating people with COPD across the care continuum. Additionally, significant funding is provided to ensure that quality clinical research is conducted into chronic respiratory conditions, and to maintain national monitoring and surveillance measures.
In 2018, the US high-flow nasal cannula market held the largest share of the North America high-flow nasal cannula market because it has highest COPD prevalence. During the year 2013 to 2017, an estimated 2.4 million U.S. working adults aged above 18 years had COPD who never smoked. The highest COPD prevalence among non-smokers were in the information (3.3%) and mining (3.1%) industries and office and administrative support occupation workers (3.3%).
The hospital segment expected to dominate the North America high-flow nasal cannula market. Additionally, this segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027. Similarly, in 2018 the active humidifier segment held the major market share among the component segments.
By Component, the active humidifier segment held a largest market share of the high-flow nasal cannula market, in 2018. The active humidifier is expected to dominate its market share in 2027 because for invasive and non-invasive ventilation, there are many players who provide this by heated circuits and systems. The active humidifier segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.
Chronic Obstructive Pulmonary Disease segment a largest market share of the high-flow nasal cannula market, by application in 2018. However, bronchiectasis segment expected to have largest market in 2027 because patients with bronchiectasis are growing consistently since 2001 and its prevalence is more in elder population.
Some of the major primary and secondary sources for drug delivery systems included in the report are the American Thoracic Society (ATS) and the global initiative for Chronic Lung Disease (GOLD), NCD Alliance, etc.